Literature DB >> 2403226

Nasal physiology and inflammatory mediators during natural pollen exposure.

D P Skoner1, L Lee, W J Doyle, S Boehm, P Fireman.   

Abstract

Nasal allergen challenges in allergic rhinitis subjects provoke characteristic alterations in nasal and eustachian tube (ET) function. The purpose of this study was to examine the effect of natural pollen exposure on nasal physiology and inflammatory mediators. Grass pollen counts, ET function (sonotubometry), nasal resistance (rhinomanometry), symptoms, mediator levels (saline wash), and skin test reactivity in nine adults with grass allergy were monitored weekly before (week 1), during (weeks 2 to 9) and after (weeks 10 and 11) grass pollen season. Pollen counts peaked at week 3, and then decreased gradually. Mean nasal resistance (cm H2O/L/sec) increased from a baseline of 2.4 +/- 0.5 to 3.7 +/- 1.1 at week 3, peaked at week 4 (5.3 +/- 1.2), remained elevated (weeks 5-8), peaked again at week 9 (6.6 +/- 1.4), and then decreased, Bilateral ET obstruction was not present in any of the subjects at baseline, but was present in five of the nine subjects at week 4. Symptom severity paralleled grass pollen counts. Peak mediator levels were observed at weeks 2 and 9 for histamine and at weeks 3 and 10 for leukotriene C4. Seasonal increases in grass and histamine-induced wheal sizes were also observed. These data show that measurable changes in the function of the nose and ET and the levels of nasal mediators and dermal reactivity accompany and track pollen counts during seasonal exposure and suggest that therapy for seasonal allergic rhinitis should be (1) directed at reducing airway inflammation and (2) continued well beyond the time of peak pollen exposure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403226

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  8 in total

Review 1.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 2.  Glucocorticosteroids in allergic inflammation: clinical benefits in otitis media with effusion.

Authors:  Ingeborg Dhooge; Katia Verbruggen; Liesbet Vandenbulcke
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

3.  Immunosuppressive effect of sinomenine in an allergic rhinitis mouse model.

Authors:  Zhe Chen; Ze-Zhang Tao; Xu-Hong Zhou; Ting-Ting Wu; Lin-Feng Ye
Journal:  Exp Ther Med       Date:  2017-03-20       Impact factor: 2.447

4.  Intracellular delivery of nanoparticles of an antiasthmatic drug.

Authors:  Naazneen Surti; Sachin Naik; Tamishraha Bagchi; B S Dwarkanath; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2008-02-07       Impact factor: 3.246

Review 5.  Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update.

Authors:  Helen Van Hoecke; Liesbet Vandenbulcke; Paul Van Cauwenberge
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  The upper airway response to pollen is enhanced by exposure to combustion particulates: a pilot human experimental challenge study.

Authors:  Russ Hauser; Timothy M Rice; G G Krishna Murthy; Matt P Wand; Daniel Lewis; Toni Bledsoe; Joseph Paulauskis
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

Review 7.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

Review 8.  Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases.

Authors:  Olavo de Godoy Mion; João Ferreira de Mello; Daniel Lorena Dutra; Nilvano Alves de Andrade; Washington Luiz de Cerqueira Almeida; Wilma Teresinha Anselmo-Lima; Leonardo Lopes Balsalobre Filho; Jair de Carvalho E Castro; Roberto Eustáquio Dos Santos Guimarães; Marcus Miranda Lessa; Sérgio Fabrício Maniglia; Roberto Campos Meireles; Márcio Nakanishi; Shirley Shizue Nagata Pignatari; Renato Roithmann; Fabrizio Ricci Romano; Rodrigo de Paula Santos; Marco César Jorge Dos Santos; Edwin Tamashiro
Journal:  Braz J Otorhinolaryngol       Date:  2017-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.